Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Pore-forming venoms as a senolytic strategy

Venom peptides exhibit diverse pharmacology with attractive drug-like traits such as selectivity, safety, bioavailability and stability. Here, we report a distinct class of senolytics, the ‘senotoxins’, that are inspired by animal venoms. Compared with normal cells, senescent cells exhibit heightened vulnerability to venom-derived pore-forming proteins that disrupt membrane integrity and homeostasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Lipid–StnIG interactions and in vivo activity of StnIG.

References

  1. Munoz-Espin, D. & Serrano, M. Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol. 15, 482–496 (2014). A comprehensive overview of the physiological roles of cellular senescence in development and tissue repair, as well as its contribution to aging and disease.

    Article  PubMed  CAS  Google Scholar 

  2. McHugh, D., Durán, I. & Gil, J. Senescence as a therapeutic target in cancer and age-related diseases. Nat. Rev. Drug Discov. 24, 57–71 (2024). A review of senolytics and senomorphics as a transformative strategies for eliminating senescent cells, suppressing inflammation, and addressing root causes of cancer and age-related diseases.

    Article  PubMed  Google Scholar 

  3. Colucci, M., Sarill, M., Lee, S. & Patel, R. Senescence in cancer. Cancer Cell 43, 1204–1226 (2025). A review discussing the paradoxical role of cellular senescence in cancer.

    Article  PubMed  CAS  Google Scholar 

  4. Chaib, S., Tchkonia, T. & Kirkland, J. L. Cellular senescence and senolytics: the path to the clinic. Nat. Med. 28, 1556–1568 (2022). A review examining the clinical potential of senolytics and the progress towards translating them into therapies for age-related diseases.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Arranz, R. et al. Elucidating the structure and assembly mechanism of actinoporin pores in complex membrane environments. Sci. Adv. https://doi.org/10.1126/sciadv.adv0683 (2025). A research article describing, based on cryo-electron microscopy models, how actinoporins (including sticholysins) assemble into membrane pores.

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Moral-Sanz, J. et al. Senotoxins target senescence via lipid binding specificity, ion imbalance and lipidome remodeling. Nat. Aging https://doi.org/10.1038/s43587-025-01030-w (2026).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pore-forming venoms as a senolytic strategy. Nat Aging (2026). https://doi.org/10.1038/s43587-026-01070-w

Download citation

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s43587-026-01070-w

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer